These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3788661)

  • 1. [The effect of hemofiltration on elevated levels of serum lipids in patients with chronic kidney failure].
    Jeren-Struić B; Prejac M; Horvatin-Godler S
    Acta Med Iugosl; 1986; 40(4):285-91. PubMed ID: 3788661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hemodialysis on blood hormone and lipid levels in patients with chronic kidney failure].
    Dzhavad-Zade MD; Agaev MM; Agabalaeva LI; Karaev ME; Movla-Zade NG
    Med Radiol (Mosk); 1987 Feb; 32(2):18-20. PubMed ID: 3807717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of serum lipids and lipoproteins in renal disease].
    Synková J; Groh J; Sedová J; Mejtská M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):373-84. PubMed ID: 6977835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Loss of amino acids caused by hemofiltration].
    Torrente J; Naranjo P; Ruiz González MC; Rentero R; D'Ocón MT
    Med Clin (Barc); 1984 Jun; 83(5):192-4. PubMed ID: 6482579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorders of serum lipid and protein composition in patients with chronic renal failure].
    Markiewicz K; Walasek L; Lutz W
    Pol Tyg Lek; 1972 Jan; 27(4):131-3. PubMed ID: 5010168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in serum lipids in chronic renal insufficiency and failure].
    Polácková H; Osten J; Válková D
    Vnitr Lek; 1981 Nov; 27(11):1091-7. PubMed ID: 7314548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relationship between serum myoinositol and serum lipid concentrations in patients with chronic renal failure].
    Trznadel K; Walasek L; Lutz W
    Pol Tyg Lek; 1977 Apr; 32(14):531-4. PubMed ID: 854467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum lipids in chronic kidney failure and their modification with glucose and sorbitol during peritoneal dialysis].
    Reimold WV; Kattermann R; Quellhorst E
    Arch Klin Med; 1969; 216(5):384-401. PubMed ID: 5371209
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen (author's transl)].
    Prejac M; Mikulicic V; Jeren-Struić B; Kozjak D
    Lijec Vjesn; 1980; 102(7-8):386-91. PubMed ID: 6169969
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood lipids in renal amyloidosis].
    Srinivas KV; Neverov NI; Kolonduk NV; Tambovtseva EV; Kozlova RI
    Urol Nefrol (Mosk); 1993; (1):28-31. PubMed ID: 7941122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis].
    Wang C; Lou TQ; Tang H; Chen ZJ; Yin PD; Yu XQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):753-5. PubMed ID: 15585154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid metabolism in chronic pyelonephritis].
    Liul'ko AV; Kropinov PI; Romanenko SA
    Vrach Delo; 1982 May; (5):25-9. PubMed ID: 7113130
    [No Abstract]   [Full Text] [Related]  

  • 15. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis.
    Gugliucci A; Schulze J; Kinugasa E; Ogata H; Kimura S
    Clin Chim Acta; 2009 Apr; 402(1-2):209-10. PubMed ID: 19150443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of nicotinic acid and miskleron on the lipid spectrum in chronic kidney failure].
    Pyrig LA; Petrun' NM; Mel'man NIa; Nikulina GG; Shinkarenko NR
    Urol Nefrol (Mosk); 1981; (3):42-5. PubMed ID: 7268975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid concentrations correlate with the progression of chronic renal failure.
    Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF
    Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.